Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
It is administered orally for the treatment of male erectile dysfunction (ED), pulmonary arterial hypertension (PAH), benign prostatic hypertrophy (BPH), or the concurrent treatment of erectile dysfunction and BPH
Looking at monthly medication costs in isolation ignores the substantial downstream healthcare savings that successful weight loss enables
This remarkable selectivity index distinguishes it from all earlier GHRPs
Patient Assistance Programs For uninsured or underinsured patients meeting income requirements, Novo Nordisk offers patient assistance that can provide medication at no cost
CJC-1295: Type: A growth hormone-releasing hormone (GHRH) analog
US$ 23.49
US$ 24.11
US$ 25.81
US$ 27.41
US$ 22.76
